Filing Details
- Accession Number:
- 0000945769-10-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-23 13:00:00
- Reporting Period:
- 2010-07-16
- Filing Date:
- 2010-07-23
- Accepted Time:
- 2010-07-23 14:13:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463338 | M Bryce Harvey | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-07-16 | 2,500 | $9.93 | 2,500 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2010-07-16 | 1,250 | $5.83 | 3,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-16 | 2,800 | $20.49 | 950 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-07-16 | 950 | $20.49 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-16 | 2,500 | $0.00 | 2,500 | $9.93 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-07-16 | 1,250 | $0.00 | 1,250 | $5.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2008-12-28 | 2017-12-28 | No | 4 | M | Direct |
3,750 | 2009-11-13 | 2018-11-13 | No | 4 | M | Direct |
Footnotes
- Stock Options were granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- The option becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- Other than the option to acquire 2,500 and 3,750 shares reflected on this form as still held by Mr. Harvey , Mr. Harvey is also the holder of an additional option to acquire 5,000 shares of Hi-Tech Common Stock, (for aggregate options to acquire a total of 11,250 shares currently held by Mr. Harvey), which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.